| A review of central 5-HT receptors and their function NM Barnes, T Sharp Neuropharmacology 38 (8), 1083-1152, 1999 | 4106 | 1999 |
| Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis R Upthegrove, N Manzanares-Teson, NM Barnes Schizophrenia research 155 (1-3), 101-108, 2014 | 549 | 2014 |
| The Concise Guide to PHARMACOLOGY 2021/22: G protein‐coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ... British journal of pharmacology 178, S27-S156, 2021 | 473 | 2021 |
| The concise guide to pharmacology 2017/18: overview SPH Alexander, E Kelly, NV Marrion, JA Peters, E Faccenda, SD Harding, ... British journal of pharmacology 174, S1-S16, 2017 | 309 | 2017 |
| The 5-HT3 receptor–the relationship between structure and function NM Barnes, TG Hales, SCR Lummis, JA Peters Neuropharmacology 56 (1), 273-284, 2009 | 309 | 2009 |
| 5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue JM Barnes, NM Barnes, B Costall, RJ Naylor, MB Tyers Nature 338 (6218), 762-763, 1989 | 307 | 1989 |
| The concise guide to PHARMACOLOGY 2015/16: Overview SPH Alexander, E Kelly, N Marrion, JA Peters, HE Benson, E Faccenda, ... British journal of pharmacology 172 (24), 5729-5743, 2015 | 244 | 2015 |
| Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells A Serafeim, MJ Holder, G Grafton, A Chamba, MT Drayson, QT Luong, ... Blood, The Journal of the American Society of Hematology 101 (8), 3212-3219, 2003 | 211 | 2003 |
| Serotonin syndrome: pathophysiology, clinical features, management, and potential future directions WJ Scotton, LJ Hill, AC Williams, NM Barnes International Journal of Tryptophan Research 12, 1178646919873925, 2019 | 209 | 2019 |
| Is central hyperacusis a symptom of 5-hydroxytryptamine (5-HT) dysfunction? J Marriage, NM Barnes The Journal of Laryngology & Otology 109 (10), 915-921, 1995 | 201 | 1995 |
| Lymphocytes transport serotonin and dopamine: agony or ecstasy? J Gordon, NM Barnes Trends in immunology 24 (8), 438-443, 2003 | 180 | 2003 |
| International Union of Basic and Clinical Pharmacology. CX. Classification of receptors for 5-hydroxytryptamine; pharmacology and function NM Barnes, GP Ahern, C Becamel, J Bockaert, M Camilleri, ... Pharmacological reviews 73 (1), 310-520, 2021 | 178 | 2021 |
| Angiofensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's disease NM Barnes, CHK Cheng, B Costall, RJ Naylor, TJ Williams, CM Wischik European journal of pharmacology 200 (2-3), 289-292, 1991 | 175 | 1991 |
| Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses T Rowland, BI Perry, R Upthegrove, N Barnes, J Chatterjee, D Gallacher, ... The British Journal of Psychiatry 213 (3), 514-525, 2018 | 164 | 2018 |
| Consensus meeting agrees distribution of 5-HT3 receptors in mammalian hindbrain GD Pratt, NG Bowery, GJ Kilpatrick, RA Leslie, NM Barnes, RJ Naylor, ... Trends in pharmacological sciences 11 (4), 135-137, 1990 | 163 | 1990 |
| Central 5-HT receptors and their function; present and future T Sharp, NM Barnes Neuropharmacology 177, 108155, 2020 | 154 | 2020 |
| Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the rat JM Barnes, NM Barnes, S Champaneria, B Costall, RJ Naylor Neuropharmacology 29 (11), 1037-1045, 1990 | 151 | 1990 |
| Alterations in angiotensin AT1 and AT2 receptor subtype levels in brain regions from patients with neurodegenerative disorders J Ge, NM Barnes European journal of pharmacology 297 (3), 299-306, 1996 | 147 | 1996 |
| Ability of angiotensin II to modulate striatal dopamine release via the AT1 receptor in vitro and in vivo DC Brown, LJ Steward, J Ge, NM Barnes British journal of pharmacology 118 (2), 414-420, 1996 | 140 | 1996 |
| Cellular localization of AT1 receptor mRNA and protein in normal placenta and its reduced expression in intrauterine growth restriction. Angiotensin II stimulates the release … X Li, M Shams, J Zhu, A Khalig, M Wilkes, M Whittle, N Barnes, A Ahmed The Journal of clinical investigation 101 (2), 442-454, 1998 | 137 | 1998 |
